Literature DB >> 11339363

CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification.

M Fujimoto1, J C Poe, M Hasegawa, T F Tedder.   

Abstract

The fate of B lymphocytes is dependent on intrinsic and B cell antigen receptor (BCR)-induced signals. These signals are interpreted and modified by response regulators such as CD19 that govern mature B cell activation. The current understanding of how CD19 governs B lymphocyte signaling is outlined in this review. Primarily, CD19 establishes a novel Src-family kinase amplification loop that regulates basal signal transduction thresholds in resting B cells. Moreover, CD19 amplifies Src-family kinase activation following BCR ligation. CD19 amplification of Lyn activity leads to processive phosphorylation of CD19 and downstream substrates including CD22. Phosphorylated CD19 recruits other effector molecules including Vav, Grb2, phosphoinositide 3-kinase, phospholipase Cgamma2, and c-Abl, which may contribute to CD19 regulation of B cell function. CD19/Lyn complex formation also regulates phosphorylation of CD22 and FcgammaRIIB, which inhibit B cell signal transduction through the recruitment of the SHPI and SHIP phosphatases. These observations provide insight into how CD19 governs the molecular ordering and intensity of signals transduced in B cells, and how perturbations in CD19 expression or signaling function may contribute to autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11339363     DOI: 10.1385/IR:22:2-3:281

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  94 in total

1.  CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.

Authors:  M Fujimoto; J C Poe; P J Jansen; S Sato; T F Tedder
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

2.  CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.

Authors:  L M O'Rourke; R Tooze; M Turner; D M Sandoval; R H Carter; V L Tybulewicz; D T Fearon
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

Review 3.  The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity.

Authors:  T F Tedder; M Inaoki; S Sato
Journal:  Immunity       Date:  1997-02       Impact factor: 31.745

Review 4.  PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond.

Authors:  B M Marte; J Downward
Journal:  Trends Biochem Sci       Date:  1997-09       Impact factor: 13.807

5.  Specific stimulation of c-Fgr kinase by tyrosine-phosphorylated (poly)peptides--possible implication in the sequential mode of protein phosphorylation.

Authors:  M Ruzzene; A M Brunati; A Donella-Deana; O Marin; L A Pinna
Journal:  Eur J Biochem       Date:  1997-05-01

6.  Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling.

Authors:  B S Hostager; I M Catlett; G A Bishop
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

7.  CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.

Authors:  T F Tedder; S Sato; J C Poe; M Fujimoto
Journal:  Keio J Med       Date:  2000-03

8.  Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.

Authors:  N J Chalupny; A Aruffo; J M Esselstyn; P Y Chan; J Bajorath; J Blake; L K Gilliland; J A Ledbetter; M A Tepper
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

9.  Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.

Authors:  L J Zhou; H M Smith; T J Waldschmidt; R Schwarting; J Daley; T F Tedder
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization.

Authors:  A M Buhl; C M Pleiman; R C Rickert; J C Cambier
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  23 in total

Review 1.  How does B cell depletion therapy work, and how can it be improved?

Authors:  E A Clark; J A Ledbetter
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

2.  CD19 expression in B cells is important for suppression of contact hypersensitivity.

Authors:  Rei Watanabe; Manabu Fujimoto; Nobuko Ishiura; Yoshihiro Kuwano; Hiroko Nakashima; Norihito Yazawa; Hitoshi Okochi; Shinichi Sato; Thomas F Tedder; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

3.  Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.

Authors:  Elizabeth O Lobo; Zhifang Zhang; John E Shively
Journal:  J Leukoc Biol       Date:  2009-05-19       Impact factor: 4.962

4.  CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody.

Authors:  Farrukh T Awan; Rosa Lapalombella; Rossana Trotta; Jonathan P Butchar; Bo Yu; Don M Benson; Julie M Roda; Carolyn Cheney; Xiaokui Mo; Amy Lehman; Jeffrey Jones; Joseph Flynn; David Jarjoura; John R Desjarlais; Susheela Tridandapani; Michael A Caligiuri; Natarajan Muthusamy; John C Byrd
Journal:  Blood       Date:  2009-12-02       Impact factor: 22.113

5.  The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.

Authors:  Alexandra I Ziegler; Melanie A Le Page; Mhairi J Maxwell; Jessica Stolp; Haoyao Guo; Abhirup Jayasimhan; Margaret L Hibbs; Pere Santamaria; Jacques F Miller; Magdalena Plebanski; Pablo A Silveira; Robyn M Slattery
Journal:  Diabetologia       Date:  2013-09-08       Impact factor: 10.122

Review 6.  Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.

Authors:  Noam Jacob; William Stohl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 7.  B-cell-targeted therapies in systemic lupus erythematosus.

Authors:  Vera Sau-Fong Chan; Helen Hoi-Lun Tsang; Rachel Chun-Yee Tam; Liwei Lu; Chak-Sing Lau
Journal:  Cell Mol Immunol       Date:  2013-01-28       Impact factor: 11.530

8.  Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.

Authors:  Michelle K Gleason; Michael R Verneris; Deborah A Todhunter; Bin Zhang; Valarie McCullar; Sophia X Zhou; Angela Panoskaltsis-Mortari; Louis M Weiner; Daniel A Vallera; Jeffrey S Miller
Journal:  Mol Cancer Ther       Date:  2012-10-17       Impact factor: 6.261

9.  CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling.

Authors:  Yohei Iwata; Ayumi Yoshizaki; Kazuhiro Komura; Kazuhiro Shimizu; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Sangjae Bae; Motoi Takenaka; Toru Yukami; Minoru Hasegawa; Manabu Fujimoto; Yasushi Tomita; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

10.  Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.